The bladder cancer market is projected to reach $16 billion across 8 major markets (8MM) by 2033, driven by new therapies and ...

"Prior to the EV-302 clinical trial, the treatment of advanced bladder cancer treatment hadn't significantly changed since ...

While this new treatment offers a vital lifeline, experts are simultaneously stressing the critical importance of recognising ...

Treatment for advanced bladder cancer had not significantly changed for 40 years. Now thousands are set to benefit ...

The combination will now join Bristol Myers Squibb’s Opdivo in the list of bladder cancer drugs available on the NHS.

First new treatment for advanced bladder cancer in decades given green light - Experts said the approval of the new treatment ...

Pfizer is making significant strides in the oncology sector, boasting a robust lineup of cancer treatments. Its oncology ...

Pfizer Inc. just got a price target bump from Citi. Following a robust Q2, Citi upgraded Pfizer's price target from $25 to ...

Following the company’s strong Q2 performance, Citi raised its price target on Pfizer Inc. (NYSE:PFE) from $25 to $26 on ...

We recently published 10 Stocks Jim Cramer Discussed As He Questioned Official Data. Pfizer Inc. (NYSE:PFE) is one of the ...